Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-10

Clinical Trial Update: Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports results on whether the anti-inflammatory drug etanercept modulates inflammation in inflammatory rheumatisms, focusing on psoriati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Inflammatory Rheumatism, Psoriatic Arthritis | Phase 3 | Status: COMPLETED